Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.01% is 100% above its 5-year average of -102.28%, near the high end of its 5-year range (-215.27%–-0.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 99.97% above its 12-month average of -48.51%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.01%.
RETURN ON EQUITY (ROE)
-0.01%
RETURN ON EQUITY (ROE) AVG TTM
-48.51%
RETURN ON EQUITY (ROE) AVG 3Y
-109.80%
RETURN ON EQUITY (ROE) AVG 5Y
-102.28%
RETURN ON EQUITY (ROE) AVG 10Y
-75.87%
RETURN ON EQUITY (ROE) AVG 15Y
-77.80%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+99.97%
CURRENT VS 3Y AVG
+99.99%
CURRENT VS 5Y AVG
+99.99%
CURRENT VS 10Y AVG
+99.98%
CURRENT VS 15Y AVG
+99.98%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
+99.96%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$443.61M
Return on Equity (ROE)
-0.01%
TTM Avg
-48.51%
3Y Avg
-109.80%
5Y Avg
-102.28%
Market Cap
$434.84M
Return on Equity (ROE)
-52.56%
TTM Avg
-31.09%
3Y Avg
-101.75%
5Y Avg
-86.54%
Market Cap
$432.00M
Return on Equity (ROE)
-70.24%
TTM Avg
-381.56%
3Y Avg
-217.03%
5Y Avg
-155.40%
Market Cap
$457.20M
Return on Equity (ROE)
-97.92%
TTM Avg
-59.21%
3Y Avg
-49.84%
5Y Avg
-46.25%
Market Cap
$462.23M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$462.71M
Return on Equity (ROE)
-24.02%
TTM Avg
-22.16%
3Y Avg
-34.88%
5Y Avg
-37.32%
Market Cap
$463.29M
Return on Equity (ROE)
8.25%
TTM Avg
6.54%
3Y Avg
3.79%
5Y Avg
3.91%
Market Cap
$465.59M
Return on Equity (ROE)
-6.60%
TTM Avg
-10.82%
3Y Avg
-11.36%
5Y Avg
-7.59%
Market Cap
$472.58M
Return on Equity (ROE)
-9.69%
TTM Avg
-30.79%
3Y Avg
-49.02%
5Y Avg
-53.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $443.61M | -0.01% | -48.51% | -109.80% | -102.28% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | -52.56% | -31.09% | -101.75% | -86.54% |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | -70.24% | -381.56% | -217.03% | -155.40% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $457.20M | -97.92% | -59.21% | -49.84% | -46.25% |
| NRC Health (NRC)vs › | $462.23M | 89.43% | 81.07% | 67.39% | 61.90% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.71M | -24.02% | -22.16% | -34.88% | -37.32% |
| Kamada Ltd. (KMDA)vs › | $463.29M | 8.25% | 6.54% | 3.79% | 3.91% |
| NeoGenomics, Inc. (NEO)vs › | $465.59M | -6.60% | -10.82% | -11.36% | -7.59% |
| Cerus Corporation (CERS)vs › | $472.58M | -9.69% | -30.79% | -49.02% | -53.00% |
| Carlsmed, Inc. (CARL)vs › | $412.76M | -43.14% | 2.19% | 15.11% | 15.11% |
ROE
-0.0%
ROA
-0.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -0.01% |
| 2026-03-31 | -3.21% |
| 2025-12-31 | -2.96% |
| 2025-09-30 | -21.10% |
| 2025-06-30 | -215.27% |
| 2025-03-31 | -147.12% |
| 2024-12-31 | -120.44% |
| 2024-09-30 | -156.92% |
| 2024-06-30 | -131.51% |
| 2024-03-31 | -157.53% |
| 2023-12-31 | -148.98% |
| 2023-09-30 | -174.19% |
| 2023-06-30 | -148.11% |
| 2023-03-31 | -126.47% |
| 2022-12-31 | -112.61% |
| 2022-09-30 | -127.88% |
| 2022-06-30 | -102.12% |
| 2022-03-31 | -85.66% |
| 2021-12-31 | -76.87% |
| 2021-09-30 | -48.53% |
| 2021-06-30 | -40.36% |
| 2021-03-31 | -25.36% |
| 2020-12-31 | -25.83% |
| 2020-09-30 | -18.41% |
| 2020-06-30 | -26.75% |
| 2020-03-31 | -38.62% |
| 2019-12-31 | -35.73% |
| 2019-09-30 | -61.80% |
| 2019-06-30 | -53.38% |
| 2019-03-31 | -53.34% |
| 2018-12-31 | -43.08% |
| 2018-09-30 | -29.46% |
| 2018-06-30 | -65.47% |
| 2018-03-31 | -44.08% |
| 2017-12-31 | -37.84% |
| 2017-09-30 | -108.94% |
| 2017-06-30 | -89.59% |
| 2017-03-31 | -69.53% |
| 2016-12-31 | -55.41% |
| 2016-09-30 | -44.94% |
| 2016-06-30 | -35.31% |
| 2016-03-31 | -29.55% |
| 2015-12-31 | -23.96% |
| 2015-09-30 | -21.48% |
| 2015-06-30 | -23.95% |
| 2015-03-31 | -21.56% |
| 2014-12-31 | -40.62% |
| 2014-09-30 | -50.01% |
| 2014-06-30 | -86.11% |
| 2014-03-31 | -88.01% |
| 2013-12-31 | -79.22% |
| 2013-09-30 | -57.07% |
| 2013-06-30 | -56.68% |
| 2013-03-31 | -57.90% |
| 2012-12-31 | -139.19% |
| 2012-09-30 | -189.82% |
| 2012-06-30 | -157.33% |
| 2012-03-31 | -144.52% |
| 2011-12-31 | -99.46% |
| 2011-09-30 | -47.60% |
| 2011-06-30 | -220.76% |
| 2011-03-31 | -127.61% |
| 2010-12-31 | -131.52% |
